The DOI matches its Crossref record; 45 of the 46 references it cites were found in a registry or an index.
A Distinct Replication Fork Protection Pathway Connects Fanconi Anemia Tumor Suppressors to RAD51-BRCA1/2
Open accessAbstract
Genes mutated in patients with Fanconi anemia (FA) interact with the DNA repair genes BRCA1 and BRCA2/FANCD1 to suppress tumorigenesis, but the molecular functions ascribed to them cannot fully explain all of their cellular roles. Here, we show a repair-independent requirement for FA genes, including FANCD2, and BRCA1 in protecting stalled replication forks from degradation. Fork protection is surprisingly rescued in FANCD2-deficient cells by elevated RAD51 levels or stabilized RAD51 filaments. Moreover, FANCD2-mediated fork protection is epistatic with RAD51 functions, revealing an unanticipated fork protection pathway that connects FA genes to RAD51 and the BRCA1/2 breast cancer suppressors. Collective results imply a unified molecular mechanism for repair-independent functions of FA, RAD51, and BRCA1/2 proteins in preventing genomic instability and suppressing tumorigenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“BRCA1 is implicated in a repair-independent mechanism in protecting stalled replication forks from degradation to maintain genome stability (Schlacher et al., 2012).”
From The BRCA1-Interacting Protein Abraxas Is Required for Genomic Stability and Tumor Suppression (2014) · cites this paper as Schlacher et al., 2012
In the citing paper
“As previously shown, BRCA1-deficient cells show significant shortening of fork length following hydroxyurea (HU) treatment indicating degradation of stalled replication forks.”
From The BRCA1-Interacting Protein Abraxas Is Required for Genomic Stability and Tumor Suppression (2014) · cites this paper as Schlacher et al., 2012
In the citing paper
“In addition, Abraxas did not appear to be required for efficient replication restart after HU treatment (data not shown), consistent with published observation that BRCA1 is not required for replication recovery (Schlacher et al., 2012).”
From The BRCA1-Interacting Protein Abraxas Is Required for Genomic Stability and Tumor Suppression (2014) · cites this paper as Schlacher et al., 2012
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints
Bartkova, J., Rezaei, N., Liontos, M., Karakaidos, P., Kletsas, D., Issaeva, N., Vassiliou, L.-V. F., Kolettas, E., Niforou, K., Zoumpourlis, V. C., et al. (2006) · Nature · doi:10.1038/nature05268 · Cited by 1,986
Schlacher, K., Christ, N., Siaud, N., Egashira, A., Wu, H., & Jasin, M. (2011) · Cell · doi:10.1016/j.cell.2011.03.041 · Cited by 1,292
Self-citationBrca1 Controls Homology-Directed DNA Repair
Moynahan, M. E., Chiu, J. W., Koller, B. H., & Jasin, M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80202-6 · Cited by 1,245
Self-citationInteraction of the Fanconi Anemia Proteins and BRCA1 in a Common Pathway
Garcia-Higuera, I., Taniguchi, T., Ganesan, S., Meyn, M. S., Timmers, C., Hejna, J., Grompe, M., & D'Andrea, A. D. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00173-3 · Cited by 1,198
Nucleotide deficiency promotes genomic instability in early stages of cancer development
Bester, A. C., Roniger, M., Oren, Y. S., Im, M. M., Sarni, D., Chaoat, M., Bensimon, A., Zamir, G., Shewach, D. S., & Kerem, B. (2011) · Cell · doi:10.1016/j.cell.2011.03.044 · Cited by 858
Advanced pancreatic carcinoma: current treatment and future challenges
Stathis, A., & Moore, M. J. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.236 · Cited by 791
Chen, J., Silver, D. P., Walpita, D., Cantor, S. B., Gazdar, A. F., Tomlinson, G. E., Couch, F. J., Weber, B. L., Ashley, T., Livingston, D. M., et al. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80276-2 · Cited by 635
How the Fanconi Anemia Pathway Guards the Genome
Moldovan, G., & D’Andrea, A. D. (2009) · Annual Review of Genetics · doi:10.1146/annurev-genet-102108-134222 · Cited by 601
Rad51 protects nascent DNA from Mre11-dependent degradation and promotes continuous DNA synthesis
Hashimoto, Y., Chaudhuri, A. R., Lopes, M., & Costanzo, V. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1927 · Cited by 537
The Fanconi Anemia Pathway Promotes Replication-Dependent DNA Interstrand Cross-Link Repair
Knipscheer, P., Räschle, M., Smogorzewska, A., Enoiu, M., Ho, T. V., Schärer, O. D., Elledge, S. J., & Walter, J. C. (2009) · Science · doi:10.1126/science.1182372 · Cited by 525
Flagged first, then by citations
1 of the 46 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Schroeder, 1964, [Spontaneous chromosome aberrations in familial panmyelopathy], Humangenetik, 1, 194
Cited by
Sorted by citations
Items 101–200 of 930
SIRF: Quantitative in situ analysis of protein interactions at DNA replication forks
Roy, S., Luzwick, J. W., & Schlacher, K. (2018) · The Journal of Cell Biology · doi:10.1083/jcb.201709121 · Cited by 138
Self-citationZheng, F., Zhang, Y., Chen, S., Weng, X., Rao, Y., & Hongmei, F. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109661 · Cited by 147
Two Distinct Modes of ATR Activation Orchestrated by Rad17 and Nbs1
Shiotani, B., Nguyen, H. D., Håkansson, P., Maréchal, A., Tse, A., Tahara, H., & Zou, L. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.04.018 · Cited by 142
Haynes, B. M., Murai, J., & Lee, J. (2018) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2018.09.003 · Cited by 141
What is the DNA repair defect underlying Fanconi anemia?
Duxin, J. P., & Walter, J. C. (2015) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2015.09.002 · Cited by 139
Mechanism of tandem duplication formation in BRCA1-mutant cells
Willis, N. A., Frock, R. L., Menghi, F., Duffey, E. E., Panday, A., Camacho, V., Hasty, P., Liu, E. T., Alt, F. W., & Scully, R. (2017) · Nature · doi:10.1038/nature24477 · Cited by 143
Synthetic viability by BRCA2 and PARP1/ARTD1 deficiencies
Ding, X., Chaudhuri, A. R., Callén, E., Pang, Y., Biswas, K., Klarmann, K. D., Martin, B. K., Burkett, S. S., Cleveland, L., Stauffer, S., et al. (2016) · Nature Communications · doi:10.1038/ncomms12425 · Cited by 140
Hengel, S. R., Spies, M., & Spies, M. (2017) · Cell chemical biology · doi:10.1016/j.chembiol.2017.08.027 · Cited by 136
The synthetic lethality of targeting cell cycle checkpoints and PARPs in cancer treatment
Li, S., Wang, L., Wang, Y., Zhang, C., Hong, Z., & Han, Z. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01360-x · Cited by 141
Replication stress and cancer: It takes two to tango
Lecona, E., & Fernández-Capetillo, Ó. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.09.019 · Cited by 134
BRCA1 and Breast Cancer: Molecular Mechanisms and Therapeutic Strategies
Fu, X., Tan, W., Song, Q., Pei, H., & Li, J. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.813457 · Cited by 142
Thakar, T., Leung, W., Nicolae, C. M., Clements, K. E., Shen, B., Bielinsky, A., & Moldovan, G. (2020) · Nature Communications · doi:10.1038/s41467-020-16096-w · Cited by 135
RFWD3-Dependent Ubiquitination of RPA Regulates Repair at Stalled Replication Forks
Elia, A. E. H., Wang, D. C., Willis, N. A., Boardman, A. P., Hajdú, I., Adeyemi, R. O., Lowry, E. L., Gygi, S. P., Scully, R., & Elledge, S. J. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.09.011 · Cited by 132
The Fanconi Anemia Pathway and Fertility
Tsui, V., & Crismani, W. (2019) · Trends in Genetics · doi:10.1016/j.tig.2018.12.007 · Cited by 130
Isomerization of BRCA1–BARD1 promotes replication fork protection
Daza-Martín, M., Starowicz, K., Jamshad, M., Tye, S., Ronson, G. E., Mackay, H. L., Chauhan, A. S., Walker, A. K., Stone, H. R., Beesley, J. F. J., et al. (2019) · Nature · doi:10.1038/s41586-019-1363-4 · Cited by 133
Mammalian RAD51 paralogs protect nascent DNA at stalled forks and mediate replication restart
Somyajit, K., Saxena, S., Babu, S., Mishra, A., & Nagaraju, G. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv880 · Cited by 132
RIF1 promotes replication fork protection and efficient restart to maintain genome stability
Mukherjee, C., Tripathi, V., Manolika, E. M., Heijink, A. M., Ricci, G., Merzouk, S., de Boer, H. R., Demmers, J., van Vugt, M. A. T. M., & Chaudhuri, A. R. (2019) · Nature Communications · doi:10.1038/s41467-019-11246-1 · Cited by 125
Non-enzymatic roles of human RAD51 at stalled replication forks
Mason, J. M., Chan, Y., Weichselbaum, R. W., & Bishop, D. K. (2019) · Nature Communications · doi:10.1038/s41467-019-12297-0 · Cited by 125
Simoneau, A., Xiong, R., & Zou, L. (2021) · Genes & Development · doi:10.1101/gad.348479.121 · Cited by 131
APOBEC3A and APOBEC3B Activities Render Cancer Cells Susceptible to ATR Inhibition
Buisson, R., Lawrence, M. S., Benes, C. H., & Zou, L. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-3389 · Cited by 132
Replication Stress in Mammalian Cells and Its Consequences for Mitosis
Gelot, C., Magdalou, I., & López, B. S. (2015) · Genes · doi:10.3390/genes6020267 · Cited by 140
Functional Assays for Analysis of Variants of Uncertain Significance inBRCA2
Guidugli, L., Carreira, A., Caputo, S. M., Ehlén, Å., Galli, A., Monteiro, Á. N. A., Neuhausen, S. L., Hansen, T. V. O., Couch, F. J., & Vreeswijk, M. P. G. (2013) · Human Mutation · doi:10.1002/humu.22478 · Cited by 132
MRN, CtIP, and BRCA1 mediate repair of topoisomerase II–DNA adducts
Aparicio, T., Baer, R. J., Gottesman, M. E., & Gautier, J. (2016) · The Journal of Cell Biology · doi:10.1083/jcb.201504005 · Cited by 128
Rasmussen, R. D., Gajjar, M. K., Tučková, L., Jensen, K. E., Maya‐Mendoza, A., Holst, C. B., Møllgaard, K., Rasmussen, J. S., Brennum, J., Bartek, J. J., et al. (2016) · Nature Communications · doi:10.1038/ncomms13398 · Cited by 125
Przetocka, S., Porro, A., Bolck, H. A., Walker, C., Lezaja, A., Trenner, A., von Aesch, C., Himmels, S.-F., D’Andrea, A. D., Ceccaldi, R., et al. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.09.014 · Cited by 125
Godin, S. K., Sullivan, M. R., & Bernstein, K. A. (2016) · Biochemistry and Cell Biology · doi:10.1139/bcb-2016-0012 · Cited by 128
Heterochromatin-Encoded Satellite RNAs Induce Breast Cancer
Zhu, Q., Hoong, N., Aslanian, A., Hara, T., Benner, C. W., Heinz, S., Miga, K. H., Ke, E., Verma, S. K., Soroczynski, J., et al. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.04.023 · Cited by 121
Nucleases Acting at Stalled Forks: How to Reboot the Replication Program with a Few Shortcuts
Pasero, P., & Vindigni, A. (2017) · Annual Review of Genetics · doi:10.1146/annurev-genet-120116-024745 · Cited by 130
Ubiquitinated Fancd2 recruits Fan1 to stalled replication forks to prevent genome instability
Lachaud, C., Moreno, A., Marchesi, F., Toth, R. L., Blow, J. J., & Rouse, J. W. (2016) · Science · doi:10.1126/science.aad5634 · Cited by 119
Fanconi Anemia Signaling and Cancer
Nepal, M. K., Che, R., Zhang, J., Ma, C., & Fei, P. (2017) · Trends in cancer · doi:10.1016/j.trecan.2017.10.005 · Cited by 125
The Mechanisms of Action of Tumor Treating Fields
Moser, J. C., Salvador, E., Deniz, K., Swanson, K. D., Tuszyński, J. A., Carlson, K. W., Karanam, N. K., Patel, C. B., Story, M. D., Lou, E., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-22-0887 · Cited by 122
Williams, G. J., Hammel, M., Radhakrishnan, S. K., Ramsden, D. A., Lees‐Miller, S. P., & Tainer, J. A. (2014) · DNA repair · doi:10.1016/j.dnarep.2014.02.009 · Cited by 116
Targeting ATR in patients with cancer
Ngoi, N. Y. L., Pilie, P. G., McGrail, D. J., Zimmermann, M., Schlacher, K., & Yap, T. A. (2024) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-024-00863-5 · Cited by 119
Self-citationBRCA1 and S phase DNA repair pathways restrict LINE-1 retrotransposition in human cells
Mita, P., Sun, X., Fenyö, D., Kahler, D. J., Li, D., Agmon, N., Wudzinska, A., Keegan, S., Bader, J. S., Yun, C., et al. (2020) · Nature Structural & Molecular Biology · doi:10.1038/s41594-020-0374-z · Cited by 113
Ragupathi, A., Singh, M., Perez, A. M., & Zhang, D. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1133472 · Cited by 120
PARP Trapping Beyond Homologous Recombination and Platinum Sensitivity in Cancers
Murai, J., & Pommier, Y. G. (2018) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030518-055914 · Cited by 114
Higgs, M. R., Sato, K., Reynolds, J. J., Begum, S., Bayley, R., Goula, A., Vernet, A., Paquin, K. L., Skalnik, D. G., Kobayashi, W., et al. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.05.018 · Cited by 110
FANCD2 regulates BLM complex functions independently of FANCI to promote replication fork recovery
Chaudhury, I., Sareen, A., Raghunandan, M., & Sobeck, A. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt348 · Cited by 115
Lafrance‐Vanasse, J., Williams, G. J., & Tainer, J. A. (2015) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2014.12.004 · Cited by 115
Structure of the Fanconi anaemia monoubiquitin ligase complex
Shakeel, S., Rajendra, E., Alcón, P., O’Reilly, F. J., Chorev, D. S., Maslen, S., Degliesposti, G., Russo, C. J., He, S., Hill, C. H., et al. (2019) · Nature · doi:10.1038/s41586-019-1703-4 · Cited by 107
BRCA Mutations in Prostate Cancer: Assessment, Implications and Treatment Considerations
Shah, S., Rachmat, R., Enyioma, S., Ghose, A., Revythis, A., & Boussios, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312628 · Cited by 113
Clinical approaches to overcome PARP inhibitor resistance
Zou, Y., Zhang, H., Chen, P., Tang, J., Yang, S., Nicot, C., Guan, Z., Li, X., & Tang, H. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02355-1 · Cited by 118
Schoonen, P. M., Talens, F., Stok, C., Gogola, E., Heijink, A. M., Bouwman, P., Foijer, F., Tarsounas, M., Blatter, S., Jonkers, J., et al. (2017) · Nature Communications · doi:10.1038/ncomms15981 · Cited by 108
Verma, P., Dilley, R. L., Zhang, T., Gyparaki, M. T., Li, Y., & Greenberg, R. A. (2019) · Genes & Development · doi:10.1101/gad.319723.118 · Cited by 107
SAU, A. C., Lau, R., Cabrita, M. A., Nolan, E., Crooks, P. A., Visvader, J. E., & Pratt, M. A. C. (2016) · Cell stem cell · doi:10.1016/j.stem.2016.05.003 · Cited by 109
Targeting DNA repair in cancer: current state and novel approaches
Klinakis, A., Karagiannis, D., & Rampias, T. N. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03299-8 · Cited by 108
Sequential role of RAD51 paralog complexes in replication fork remodeling and restart
Berti, M., Teloni, F., Mijic, S., Ursich, S., Fuchs, J., Palumbieri, M. D., Krietsch, J., Schmid, J. A., Garcin, E. B., Gon, S., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17324-z · Cited by 104
PARP1: Structural insights and pharmacological targets for inhibition
Spiegel, J. O., Houten, B. V., & Durrant, J. D. (2021) · DNA repair · doi:10.1016/j.dnarep.2021.103125 · Cited by 108
Exploiting replication gaps for cancer therapy
Cong, K., & Cantor, S. B. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.04.023 · Cited by 107
Schmid, J. A., Berti, M., Walser, F., Raso, M. C., Schmid, F. M., Krietsch, J., Stoy, H., Zwicky, K., Ursich, S., Freire, R., et al. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.07.011 · Cited by 105
Marco, S. D., Hašanová, Z., Kanagaraj, R., Chappidi, N., Altmannová, V., Menon, S., Polášek-Sedláčková, H., Langhoff, J., Surendranath, K., Hühn, D., et al. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.05.006 · Cited by 106
How do mutations affecting the breast cancer genes BRCA1 and BRCA2 cause cancer susceptibility?
Venkitaraman, A. R. (2019) · DNA repair · doi:10.1016/j.dnarep.2019.102668 · Cited by 111
Karanam, N. K., Ding, L., Asaithamby, A., & Story, M. D. (2019) · Translational research · doi:10.1016/j.trsl.2019.10.003 · Cited by 104
PTEN regulates RPA1 and protects DNA replication forks
Wang, G., Li, Y., Wang, P., Liang, H., Cui, M., Zhu, M., Guo, L., Su, Q. P., Sun, Y., McNutt, M. A., et al. (2015) · Cell Research · doi:10.1038/cr.2015.115 · Cited by 100
Liu, W., Krishnamoorthy, A., Zhao, R., & Cortez, D. (2020) · Science Advances · doi:10.1126/sciadv.abc3598 · Cited by 99
RAD51 bypasses the CMG helicase to promote replication fork reversal
Liu, W., Saito, Y., Jackson, J., Bhowmick, R., Kanemaki, M. T., Vindigni, A., & Cortez, D. (2023) · Science · doi:10.1126/science.add7328 · Cited by 99
A new protein complex promoting the assembly of Rad51 filaments
Sasanuma, H., Tawaramoto, M. S., Lao, J. P., Hosaka, H., Sanda, E., Suzuki, M., Yamashita, E., Hunter, N., Shinohara, M., Nakagawa, A., et al. (2013) · Nature Communications · doi:10.1038/ncomms2678 · Cited by 107
Karanja, K. K., Cox, S. W., Duxin, J. P., Stewart, S. A., & Campbell, J. L. (2012) · Cell Cycle · doi:10.4161/cc.22215 · Cited by 100
Multifaceted Fanconi Anemia Signaling
Che, R., Zhang, J., Nepal, M. K., Han, B., & Fei, P. (2017) · Trends in Genetics · doi:10.1016/j.tig.2017.11.006 · Cited by 97
RADX Modulates RAD51 Activity to Control Replication Fork Protection
Bhat, K. P., Krishnamoorthy, A., Dungrawala, H., Garcin, E. B., Modesti, M., & Cortez, D. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.06.061 · Cited by 97
Systematic screening reveals a role for BRCA1 in the response to transcription-associated DNA damagePreprint
Hill, S. J., Rolland, T., Adelmant, G., Xia, X., Owen, M., Dricot, A., Zack, T. I., Sahni, N., Jacob, Y., Hao, T., et al. (2014) · Genes & Development · doi:10.1101/gad.241620.114 · Cited by 102
Kutler, D. I., Patel, K. R., Auerbach, A. D., Kennedy, J. A., Lach, F. P., Sanborn, E. M., Cohen, M. A., Kuhel, W. I., & Smogorzewska, A. (2015) · The Laryngoscope · doi:10.1002/lary.25726 · Cited by 96
Chappell, W. H., Gautam, D., Ok, S. T., Johnson, B. A., Anacker, D. C., & Moody, C. A. (2015) · Journal of Virology · doi:10.1128/jvi.02495-15 · Cited by 97
Deciphering the BRCA1 Tumor Suppressor Network
Jiang, Q., & Greenberg, R. A. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.r115.667931 · Cited by 96
Nek1 Regulates Rad54 to Orchestrate Homologous Recombination and Replication Fork Stability
Spies, J., Waizenegger, A., Barton, O., Sürder, M., Wright, W. D., Heyer, W., & Löbrich, M. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.04.032 · Cited by 97
FANCD2 limits replication stress and genome instability in cells lacking BRCA2
Michl, J., Zimmer, J., Buffa, F. M., McDermott, U., & Tarsounas, M. (2016) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3252 · Cited by 95
BLM helicase regulates DNA repair by counteracting RAD51 loading at DNA double-strand break sites
Patel, D. S., Misenko, S. M., Her, J., & Bunting, S. F. (2017) · The Journal of Cell Biology · doi:10.1083/jcb.201703144 · Cited by 98
Exploiting synthetic lethality to target BRCA1/2-deficient tumors: where we stand
Patel, P. S., Algouneh, A., & Hakem, R. (2021) · Oncogene · doi:10.1038/s41388-021-01744-2 · Cited by 98
Replication Stress Shapes a Protective Chromatin Environment across Fragile Genomic Regions
Kim, J., Sturgill, D. M., Sebastian, R., Khurana, S., Tran, A. D., Edwards, G. B., Kruswick, A., Burkett, S. S., Hosogane, E. K., Hannon, W. W., et al. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.11.021 · Cited by 98
BRCAness, DNA gaps, and gain and loss of PARP inhibitor–induced synthetic lethality
Li, X., & Zou, L. (2024) · Journal of Clinical Investigation · doi:10.1172/jci181062 · Cited by 98
ATR inhibition preferentially targets homologous recombination-deficient tumor cells
Krajewska, M., Fehrmann, R. S. N., Schoonen, P. M., Labib, S., de Vries, E. G. E., Franke, L., & van Vugt, M. A. T. M. (2014) · Oncogene · doi:10.1038/onc.2014.276 · Cited by 93
Polymerase δ replicates both strands after homologous recombination–dependent fork restart
Miyabe, I., Mizuno, K., Keszthelyi, A., Daigaku, Y., Skouteri, M., Mohebi, S., Kunkel, T. A., Murray, J. M., & Carr, A. M. (2015) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3100 · Cited by 98
Pefani, D., Latusek, R., Pires, I. M., Grawenda, A. M., Yee, K. S. Y., Hamilton, G., van der Weyden, L., Esashi, F., Hammond, E. M., & O’Neill, E. E. (2014) · Nature Cell Biology · doi:10.1038/ncb3035 · Cited by 93
Aggarwal, M., Banerjee, T., Sommers, J. A., Iannascoli, C., Pichierri, P., Shoemaker, R. H., & Brosh, R. M. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2975 · Cited by 91
Vallerga, M. B., Mansilla, S. F., Federico, M. B., Bertolin, A. P., & Gottifredi, V. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1508543112 · Cited by 90
A Selective Small Molecule DNA2 Inhibitor for Sensitization of Human Cancer Cells to Chemotherapy
Liu, W., Zhou, M., Li, Z., Li, H., Polaczek, P., Dai, H., Wu, Q., Liu, C., Karanja, K. K., Popuri, V., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.02.043 · Cited by 89
Self-citationReplication stress induces accumulation of FANCD2 at central region of large fragile genes
Okamoto, Y., Iwasaki, W. M., Kugou, K., Takahashi, K., Oda, A., Sato, K., Kobayashi, W., Kawai, H., Sakasai, R., Takaori‐Kondo, A., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky058 · Cited by 89
Stalled replication forks within heterochromatin require ATRX for protection
Huh, M. S., Ivanochko, D., Hashem, L. E., Curtin, M., Delorme, M., Goodall, E. C., Yan, K., & Picketts, D. J. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.121 · Cited by 94
Li, S., Lavagnino, Z., Lemacon, D. S., Kong, L., Ustione, A., Ng, X. W., Zhang, Y., Wang, Y., Zheng, B., Piwnica-Worms, H. M., et al. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.04.003 · Cited by 90
Buisson, R., Joshi, N., Pauty, J., Maity, R., Zhao, W., Coulombe, Y., Sung, P., & Masson, J. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.01.009 · Cited by 95
Unprotected Replication Forks Are Converted into Mitotic Sister Chromatid Bridges
Saada, A. A., Teixeira-Silva, A., Iraqui, I., Costes, A., Hardy, J., Paoletti, G., Fréon, K., & Lambert, S. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.04.002 · Cited by 99
Shorrocks, A.-M. K., Jones, S. E., Tsukada, K., Morrow, C. A., Belblidia, Z., Shen, J., Vendrell, I., Fischer, R., Kessler, B. M., & Blackford, A. N. (2021) · Nature Communications · doi:10.1038/s41467-020-20818-5 · Cited by 87
WRNIP1 protects stalled forks from degradation and promotes fork restart after replication stress
Leuzzi, G., Marabitti, V., Pichierri, P., & Franchitto, A. (2016) · The EMBO Journal · doi:10.15252/embj.201593265 · Cited by 89
Functions and regulation of the multitasking FANCM family of DNA motor proteinsPreprint
Xue, X., Sung, P., & Zhao, X. (2015) · Genes & Development · doi:10.1101/gad.266593.115 · Cited by 87
FANCD2 and CtIP Cooperate to Repair DNA Interstrand Crosslinks
Murina, O., von Aesch, C., Karakus, U., Ferretti, L. P., Bolck, H. A., Hänggi, K., & Sartori, A. A. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.03.069 · Cited by 92
RAD52 Prevents Excessive Replication Fork Reversal and Protects from Nascent Strand Degradation
Malacaria, E., Pugliese, G. M., Honda, M., Marabitti, V., Aiello, F. A., Spies, M., Franchitto, A., & Pichierri, P. (2018) · Nature Communications · doi:10.1038/s41467-019-09196-9 · Cited by 92
Replication Fork Reversal during DNA Interstrand Crosslink Repair Requires CMG Unloading
Amunugama, R., Willcox, S., Wu, R. A., Abdullah, U. B., El-Sagheer, A. H., Brown, T. P., McHugh, P. J., Griffith, J. D., & Walter, J. C. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.05.061 · Cited by 85
Chastain, M., Zhou, Q., Shiva, O., Fadri‐Moskwik, M., Whitmore, L. S., Jia, P., Dai, X., Huang, C., Ye, P., & Chai, W. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.06.077 · Cited by 86
RECQ5 helicase promotes resolution of conflicts between replication and transcription in human cells
Urban, V., Dobrovolná, J., Hühn, D., Fryzelková, J., Bártek, J., & Janščák, P. (2016) · The Journal of Cell Biology · doi:10.1083/jcb.201507099 · Cited by 85
Stress and DNA repair biology of the Fanconi anemia pathway
Longerich, S., Li, J., Xiong, Y., Sung, P., & Kupfer, G. M. (2014) · Blood · doi:10.1182/blood-2014-04-526293 · Cited by 85
CtIP mediates replication fork recovery in a FANCD2-regulated manner
Yeo, J. E., Lee, E. H., Hendrickson, E. A., & Sobeck, A. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu078 · Cited by 91
Costa, S., Costa, C., Madureira, J., Valdiglesias, V., Gomes, A., de Pinho, P. G., Laffón, B., & Teixeira, J. P. (2019) · Environmental Research · doi:10.1016/j.envres.2019.108740 · Cited by 84
Kanev, P.-B., Atemin, A., Stoynov, S., & Aleksandrov, R. (2023) · Seminars in Oncology · doi:10.1053/j.seminoncol.2023.08.001 · Cited by 89
Dutta, A., Eckelmann, B. J., Adhikari, S., Ahmed, K. M., Sengupta, S., Pandey, A., Hegde, P. M., Tsai, M.-S., Tainer, J. A., Weinfeld, M., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw1262 · Cited by 84
Repair pathway choice for double-strand breaks
Xu, Y., & Xu, D. (2020) · Essays in Biochemistry · doi:10.1042/ebc20200007 · Cited by 90
When Genome Maintenance Goes Badly Awry
Kass, E. M., Moynahan, M. E., & Jasin, M. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.05.021 · Cited by 84
Self-citationBRCA2 functions: from DNA repair to replication fork stabilization
Fradet‐Turcotte, A., Sitz, J., Grapton, D., & Orthwein, A. (2016) · Endocrine Related Cancer · doi:10.1530/erc-16-0297 · Cited by 91
The ZATT-TOP2A-PICH Axis Drives Extensive Replication Fork Reversal to Promote Genome Stability
Tian, T., Bu, M., Chen, X., Ding, L., Yang, Y., Han, J., Feng, X., Xu, P., Liu, T., Ying, S., et al. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.11.007 · Cited by 82
Brosh, R. M., Bellani, M. A., Liu, Y., & Seidman, M. M. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.05.005 · Cited by 84
Gupta, S. K., Smith, E. J., Mladek, A. C., Tian, S., Decker, P. A., Kizilbash, S. H., Kitange, G. J., & Sarkaria, J. N. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2018.00670 · Cited by 82
Metadata
- Authors
- Schlacher, K., Wu, H., & Jasin, M.
- Affiliations
- Memorial Sloan Kettering Cancer Center (US)
- University of California, Los Angeles (US)
- Corresponding author
- Schlacher, Katharina
- Jasin, Maria
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2012-07
- Volume
- 22
- Issue
- 1
- Pages
- 106-116
- ISSN
- 1535-6108 (ISSN-L)
- PMC
- PMC3954744
- OpenAlex
- W2096380982
- Cited by
- 936
- References
- 46
- Citations by year
- 2026: 40 · 2025: 56 · 2024: 80 · 2023: 70 · 2022: 69 · 2021: 91 · 2020: 86 · 2019: 63 · 2018: 83 · 2017: 74 · 2016: 87 · 2015: 53 · 2014: 50 · 2013: 27 · 2012: 7
- FWCI
- 17.60
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cancer Cell (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (R01CA121110, P01-CA94060, P01CA094060)
- National Institute of General Medical Sciences (R01 GM54668, R01GM054668)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
- Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
- Keywords
- Fanconi anemia, replication fork protection, FANCD2, RAD51, BRCA1, BRCA2, DNA repair, epistasis, genomic instability, tumor suppression
- MeSH terms
- Cell Line, Transformed, DNA Replication, Fanconi Anemia, Humans, Genes, BRCA1, Genes, BRCA2, BRCA2 Protein, Genomic Instability, Rad51 Recombinase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review